<DOC>
	<DOC>NCT01682694</DOC>
	<brief_summary>A common starting dose of glucosamine and chondroitin will reduce inflammation as reflected by a reduction in serum C-reactive protein.</brief_summary>
	<brief_title>Glucosamine and Chondroitin Effects</brief_title>
	<detailed_description>Use of glucosamine and chondroitin have been associated with reduced cancer and overall mortality. The aim of this study is to determine whether a common starting dose of glucosamine and chondroitin (1500 mg/d + 1200 mg/d, respectively) reduces systemic inflammation as reflected by a reduction in high sensitivity C-reactive protein.</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<criteria>Healthy Overweight (body mass index kg/m2 (BMI) between 25 and 32.5) Nonsmoking men and women Aged 2055y Chronic medical illness, history of gastrointestinal, hepatic, or renal disorders, or inflammatory conditions (including autoimmune and inflammatory diseases) Pregnancy or lactation Currently on a weightloss diet BMI (body mass index) &lt; 25 or &gt; 30 Alcohol intake of greater than 2 drinks/day Current use of prescription or overthecounter medications, (Excluding oral contraceptives and hormonesecreting IUDs), including use of aspirin or NSAIDs more than 2 days per week Abnormal renal, liver or metabolic test Inability to swallow pills Known allergy to shellfish Not willing to take pills made from shellfish or animal sources Intention to relocate out of study area within next 4 months</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>